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Thermodynamics of anesthetic/protein interactions
Temperature studies on firefly luciferase
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ABSTRACT Firefly luciferase is a soluble enzyme which is unusually sensitive to general anesthetics. The inhibition of the highly purified
enzyme by three inhalational and three alcohol general anesthetics has been studied as a function of temperature, in the range from 5 to
20°C. Inhibition constants Ki were determined at different temperatures, and van't Hoff plots of In (K1) versus reciprocal absolute
temperature were found to be linear for all agents. Analysis of these plots gave values for the standard Gibbs free energy, enthalpy and
entropy changes for transferring each anesthetic from water to the anesthetic-binding pocket on the protein. The most striking finding
was that the enthalpy changes were much more negative for anesthetics binding to the protein than for binding to lipids or simple
solvents. Furthermore, amongst the set of anesthetics studied, it was found that increasing potency correlated with favorable enthalpy
rather than entropy changes. We discuss our results with respect to the molecular mechanisms underlying general anesthesia.
INTRODUCTION
What makes a protein particularly sensitive to general
anesthetics? In view ofthe increasing evidence that anes-
thetics act directly on proteins to produce general anes-
thesia (1, 2), this has become an important question.
This matter is easiest to study with a pure soluble pro-
tein, where any possible problems due to lipid involve-
ment are absent. However, the functions ofmost soluble
proteins which have been investigated have been found
to be surprisingly insensitive to anesthetics ( 1). Fortu-
nately, there are exceptions to this rule. The best studied
ofthese is the enzyme firefly luciferase, which is sensitive
to a wide range of different anesthetics at concentrations
similar to those which induce general anesthesia in ani-
mals (3).
It is known from previous studies (3-7) that general
anesthetics inhibit firefly luciferase by binding to a hy-
drophobic pocket which normally binds its natural sub-
strate luciferin. Many other soluble proteins have sub-
strate-binding pockets with considerable hydrophobic
character; however, only a few of these appear to be sen-
sitive to a wide range of general anesthetics. What is a
mystery, therefore, is why the luciferase pocket binds so
many general anesthetics so avidly, when hydrophobic
pockets on other proteins do not. One constraint on pos-
sible solutions to this problem comes from a knowledge
of the thermodynamics of anesthetic/protein interac-
tions, an area which has been much neglected. In this
paper, we describe our first experiments on the tempera-
ture dependence of anesthetic inhibition of a protein
(firefly luciferase) and report the results of our determi-
nations of the underlying thermodynamic parameters.
MATERIALS AND METHODS
Purification and assay of firefly
luciferase
The luciferase enzyme from the North American firefly Photinus pyra-
lis was purified using affinity chromatography (8); a pure crystalline
protein was obtained (9), free of the natural substrate luciferin. The
enzyme was stored as a stock solution in 0.4 M ammonium sulfate/ 1
mM EDTA solution (pH 7.8) at 4°C. Hepps [N-(2-hydroxyethyl)-pi-
perazine-N'-( 3-propane-sulfonic acid)], ATP (disodium salt, grade I),
and D-luciferin were purchased from Sigma Chemical Co. (Poole, Dor-
set, UK). MgSO4 (Analar grade), n-butanol, n-hexanol and n-hep-
tanol (Analar grade) were obtained from BDH Ltd. (Poole, Dorset,
UK). The volatile general anesthetics were obtained from the following
sources: halothane from May & Baker Ltd. (Dagenham, Essex, UK),
methoxyflurane (Penthrane®) from Abbott Laboratories Ltd. (Queen-
borough, Kent) and diethyl ether (AR grade) from Fisons Ltd.
(Loughborough, Leicestershire, UK).
Firefly luciferase combines with its substrate luciferin in the presence
ofATP, Mg2+, and 02 to give a photon of light. Luciferase activity and
its inhibition by anesthetics over a range of temperatures were deter-
mined (see below) from the peak light output observed after rapidly
injecting 2.5 ml ofa buffered ATP solution into a reaction vial contain-
ing 5 ml of a buffered solution containing the luciferase enzyme, its
natural substrate firefly luciferin, MgSO4, and anesthetic (when appro-
priate). The buffer was 25 mM Hepps, titrated to pH 7.8 at 20°C with
NaOH. (Hepps was chosen because of its favorable pK. = 8.0 and its
low temperature coefficient: buffer pH increased by only 0.2 units on
cooling from 20°C to 5°C.) Final concentrations were 4mM ATP, 6.67
mM MgSO4, 1-45 qM luciferin, and 13 nM luciferase. Inhalational
general anesthetics were added to the reaction vial as aliquots of satu-
rated aqueous solutions.
Rapid-injection apparatus and
temperature control
Light-emitting luciferase assays were performed using a specially con-
structed temperature-controlled rapid-injection apparatus. This al-
lowed a known volume of solution in a glass syringe to be rapidly
injected (by the action of a gas-driven piston) into a glass reaction vial
(a standard 2 1-ml capacity scintillation vial) situated within a light-
tight assay chamber. The solution was delivered to the vial through a
polyvinylchloride (PVC) tube connected to the syringe via a large bore
stainless steel needle (with a Luer-lock fitting) and to the vial via a
curved stainless-steel tube passing through a rubber bung. The rubber
bung provided both a light-tight seal to the assay chamber and mechan-
ical support for the delivery tube, allowing the end of the tube to be
reproducibly positioned with respect to the reaction vial. Light from
the assay chamber passed via a shutter through a neutral density filter
to a chamber housing a photomultiplier (No. 9558B; Thorn EMI Ltd.,
Ruislip, Middlesex, UK). The signal from the photomultiplier was
taken to a variable-gain current-voltage converter, whose output was
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transiently stored on a digital storage oscilloscope. Permanent records
were produced by sending data from the oscilloscope to a chart re-
corder.
Temperature was carefully controlled as follows. The temperature of
the glass injection syringe, the assay chamber, and the connecting tub-
ing was set and maintained using a water cooler and heater/pump
(Grant Instruments Ltd., Cambridge, UK). The pump circulated
water through Dural blocks housing the assay chamber and surround-
ing the injection syringe, as well as along a large rubber tube which
enclosed the connecting PVC delivery tube. Numbered reaction vials
were prepared containing the relevant solutions (excluding enzyme
and volatile anesthetics). These were capped and then placed in a water
bath, controlled by the same heater/cooler unit, and allowed to equili-
brate to the set temperature. The temperature of a dummy vial con-
taining assay buffer was monitored with a thermocouple and digital
thermometer. Volatile agents were delivered to the vials as saturated
solutions, using a micrometer-driven glass dispensing syringe placed
inside a cooled Dural block. The anesthetic solution was added (using
an L-shaped needle) below the surface of the solution in the vial, just
prior to the assay. In all cases, the enzyme solution (101) was the very
last component to be added to the vial before ATP injection. The ATP
solution was kept in a covered beaker in the water bath, and the beaker
was removed briefly to allow the injection syringe to be loaded. The
temperature ofthe ATP solution was measured with a mercury-in-glass
thermometer. The system was calibrated by monitoring the tempera-
ture ofan assay vial during an assay by means ofa thermocouple. It was
found that the measured temperature ofthe ATP solution was an accu-
rate measure of the final assay temperature, with a small correction
factor at the lowest temperatures.
absence of inhibitor. From each (vi, v0) data pair, an estimate of the
functionf( I) was made using Eq. 1, and then an estimate ofthe inhibi-
tion constant Ki was made using Eq. 3. Finally, the mean value and
standard error of the inhibition constant Ki at each temperature were
calculated from the (typically 1O) individual estimates of Ki using the
method of weighted least squares. The weighting factors w(I), derived
by assuming a constant percentage error in the measurement of en-
zyme activity, were
w(I) = [I]2(vi/vO)2f(I)/(Ki)4. (4)
Thermodynamics of anesthetic
binding to luciferase
From the temperature dependence ofthe inhibition constant Ki for the
inhibition of firefly luciferase by each anesthetic, changes in the stan-
dard Gibbs free energy AG' enthalpy AaH l and entropy
A\soa,_" were determined for the transfer of one mole of anesthetic
from aqueous buffer to the luciferase enzyme at 200C. The standard
state used was I molar anesthetic. Data were analysed using linear van't
Hoff plots of ln (K, ) versus T-', where T is the absolute temperature.
The three thermodynamic transfer parameters and the inhibition
constant are related by the equations
ln (K1) = [AGO
_uc]I(RT)
= [ HatH .I.uc]/(RT) - [ASO,at .uj]/R, (5)
where R is the gas constant. We determined the constants c, and c2 and
their variance-covariance matrix in the equation
Inhibition of luciferase by anesthetics
Anesthetic inhibition ofthe luciferase enzyme was analyzed in terms of
a simple random binding model described previously (3, 5). Since
anesthetics compete with luciferin for binding to the enzyme, it is con-
venient to introduce ( 3 ) a functionf( I), defined as the factor by which
the apparent Michaelis constant for luciferin increases in the presence
ofinhibiting anesthetic at a free concentration [I]. It is easy to show (5 )
that
f(I) = (volvi) + ([LUc]/Km)(Vo/Vi- 1), (1)
where vo is the control activity, v, is the inhibited activity, Km is the
Michaelis constant for luciferin in the absence ofinhibitor, and [Luc] is
the luciferin concentration.
Inhibition experiments were carried out at a concentration (1 ,uM) of
luciferin far below the value of its Michaelis constant Km (which varied
from 15 ± 2 ,M at 7°C to 26 ± 2M,M at 19°C). Under these conditions,
it can be seen from Eq. 1 that the actual value ofKm has only a minor
effect on the calculated values off( I). Nonetheless, the appropriate
value ofKm was used in Eq. 1 to calculate allf( I) values.
Inhibition by the small anesthetic molecules considered in this paper
was consistent with two molecules of a given anesthetic being able to
bind independently to the enzyme, each with the same dissociation
(inhibition) constant Ki, but with only one molecule being necessary
to cause inhibition (3-5). For this case, it is easy to show (3) that
ln (Ki) = cl + c2T-', (6)
using the individual K, determinations (typically ten at each of 3 to 5
different temperatures in the range 5 to 20°C) and the method of
weighted least squares. The weighting factors for ln (K,), derived under
the same assumption as that for K1 (see Eq. 4), were
W(I) = [I]2(vi/vO)2f(I)/(Ki)2. (7)
It follows (1O) from Eqs. 5 and 6 that at To -293.15 K (i.e., 20°C),
AG2wa,4l,, ± SE = (c2 + c1T0)R
± R[ T2 Var (cl) + 2To Cov (cl, C2) + Var (C2)] 1/2, (8a)
AH at-.iuc ± SE = c2R ± R[Var (C2)] 1/2, (8b)
and
wS0atluc+SE = -c,R ±R[Var(c1)]2 (8c)
where the variance and covariance terms are the diagonal and off-
diagonal elements, respectively, of the variance-covariance matrix for
c, and c2.
Equations 8, a-c, were used to calculate the thermodynamic parame-
ters and their standard errors for the transfer of anesthetics from the
aqueous phase to the luciferase enzyme at 20°C.
f(I) = (1 + [I]/Ki )2,
RESULTS
so that
Ki = [I]l {Vf(I) - II. (3)
For the determination of the inhibition constants K, for the various
anesthetics, the inhibited activities vi were determined in duplicate at
five different anesthetic concentrations [I]; each individual inhibitor
assay was paired with a control assay, which gave the activity v, in the
Effects of temperature on the
uninhibited reaction
The highly purified firefly luciferase enzyme was studied
under conditions (4 mM ATP) in which its ATP-bind-
ing site was effectively saturated, placing the enzyme in a
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FIGURE 1 Temperature dependence of the uninhibited firefly lucifer-
ase activity. Values of the maximal activity V.. (A) and the luciferin
Michaelis constant Km (0, 0) are plotted (on logarithmic scales)
against the reciprocal of the absolute temperature. Vm.. values were
corrected for the decay which occurred during the course ofthe experi-
ment. At 19°C, the closed (0) and open (0) symbols for Km refer to
values measured at the start and finish of the experiment, respectively.
Vm, and Km values were determined at each temperature from double
reciprocal plots of (activity)-' versus (luciferin concentration)-', us-
ing the method ofweighted least squares with weighting factors propor-
tional to the squares of the activities (3). The error bars are standard
errors; where not shown, these are smaller than the symbols. The
straight lines in the figure were calculated using the method ofweighted
least squares, with weighting factors proportional to the reciprocal of
the squares of the standard errors.
form known to be highly sensitive to inhibition by a wide
range of anesthetic agents (3-6). The effects oftempera-
ture upon the uninhibited enzyme were first determined.
As reported previously (11), activity was found (not
shown) to increase with rising temperature from 6°C up
to -25°C, after which it decreased, presumably due to
thermal inactivation of the enzyme. To be certain that
our observed effects would not be complicated by ther-
mal inactivation, we chose to work in the temperature
range between 5 and 20°C.
Fig. 1 shows the behavior of Vm., and the Km for lucif-
erin as a function of reciprocal temperature (K-') over
the temperature range 7 to 19°C. It can be seen that both
parameters increased with rising temperature, but the
effect on Vmi,, (a 4.2-fold variation) was about three
times greater than the effect on Km (only a 1.7-fold varia-
tion). From the slope of the line for Vma,, the activa-
tion energy for the catalytic steps was calculated to be
(mean ± SEM) EtZ1t = 78 ± 2 kJ mol-1, which is similar
to the value of 75 kJ mol' reported by McElroy and
Seliger ( 11) under unspecified concentrations of ATP
and luciferin.
Competitive nature and stoichiometry
of anesthetic inhibition
Inhibition of firefly luciferase at room temperature by a
wide range of anesthetic molecules is competitive with
respect to luciferin (3-7). The same was found to be true
at low temperatures. This is illustrated for halothane by
the data in Fig. 2, which is a double reciprocal plot of
(activity)-' versus (luciferin concentration)` at differ-
ent concentrations of halothane at 6°C. The common
interception of the lines on the ordinate axis of Fig. 2
indicates that Vm, is unaffected by anesthetic, i.e., that
anesthetics compete with luciferin for binding to the en-
zyme.
In addition, for all anesthetics considered in this
paper, inhibition was consistent with a simple scheme
(3-5) in which two molecules of a given anesthetic can
bind independently to the enzyme, each with the same
dissociation (inhibition) constant Ki, but only one
bound molecule is necessary to cause inhibition. This
scheme predicts (see Eq. 2) that the square root off(I)
(wheref( I) is defined as the factor by which the appar-
ent Michaelis constant for luciferin increases in the pres-
ence of a concentration [I] of inhibiting anesthetic) is a
linear function of [I]. This behavior was observed for all
anesthetics used here and is illustrated in Fig. 3 for meth-
oxyflurane, at five different temperatures.
Effects of temperature on anesthetic
inhibition of luciferase
Anesthetic inhibition constants Ki were determined over
a range of temperatures. At each of 3 to 5 temperatures
and at each of 5 different anesthetic concentrations, de-
termination of the mean ± SEM of Ki involved (typi-
cally) 10 measurements of enzyme activity in the pres-
8 0 Control
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FIGURE 2 Anesthetic inhibition of firefly luciferase is competitive
with respect to luciferin at low temperatures. The reciprocal of the
luciferase activity at 6°C is plotted against the reciprocal ofthe luciferin
concentration at different concentrations ofhalothane: 0(0); 200 (*);
400 uM (U). All points but one are means oftriplicate determinations.
The error bars are standard errors; where not shown, these are smaller
than the symbols. The straight lines were calculated using the method
of weighted least squares, with weighting factors proportional to the
reciprocal of the squares of the standard errors.
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FIGURE 3 Two molecules of anesthetic interact with firefly luciferase
at all temperatures and bind with greater affinity at lower temperatures.
The square root of the functionf( I) (- the factor by which the Km for
luciferin increases in the presence of inhibitor at a concentration [I]) is
plotted against the methoxyflurane concentration at the following tem-
peratures: 7 (*); 9 (A); 12 (A); 16 (V); 19°C (-). The valuesoff(I)
were calculated from duplicate measurements of both control and in-
hibited activities, using Eq. 1. The error bars are standard errors; where
not shown, these are smaller than the symbols. Each straight line was
drawn according to the equation (see Eq. 2) Vf(I) = (1 + [I]l/Ki),
using the mean value of 10 separate determinations of the inhibition
(dissociation) constant K,.
ence and 10 measurements in the absence of anesthetic.
According to the simple binding scheme, these inhibi-
tion constants represent the equilibrium dissociation
constants for anesthetics binding to the luciferin-binding
pocket of the enzyme (5). For all agents used, Ki was
found to increase with increasing temperature, indicat-
ing that anesthetic binding decreases with increasing tem-
perature. This can be seen in Fig. 4 for the inhalational
general anesthetics and in Fig. 5 for the alcohol general
anesthetics, where the data are plotted as van't Hoffplots
of ln (Ki) versus reciprocal absolute temperature.
The six van't Hoff plots shown in Figs. 4-5 were fur-
ther analyzed to obtain values for the changes in stan-
dard Gibbs free energies, enthalpies and entropies for
transfer of anesthetics from aqueous buffer to the anes-
thetic-binding pocket on the luciferase enzyme. These
values are listed in Table 1. Since the van't Hoff plots
were linear, the enthalpy and entropy changes are con-
stant over the entire temperature range considered (from
- 5 to 20°C). The free energy changes listed, however,
refer only to 20°C; values at other temperatures can be
calculated using Eq. 5.
DISCUSSION
The temperature dependence of the binding of six anes-
thetics to the anesthetic-sensitive (high ATP) form of
firefly luciferase was studied over a temperature range
(--5 to 20°C) in which the uninhibited enzyme behaved
reasonably (Fig. 1 ) and did not suffer from thermal inac-
tivation. Inhibition was competitive (for example, see
Fig. 2) with respect to the natural substrate luciferin at
all temperatures, and two molecules of each anesthetic
could bind to the enzyme (Fig. 3). Van't Hoff plots
(Figs. 4-5) of the natural logarithm of the inhibition
constants Ki versus reciprocal absolute temperature
were linear, and quantitative analysis of these plots
yielded values for changes in the standard Gibbs free
energies, enthalpies and entropies for transfer of anes-
thetic molecules from water to the anesthetic-binding
site (see Table 1 ).
The values of the standard Gibbs free energy changes
AGO at 20°C are quite precise, the largest standard
error being less than 0.6% of the mean. They show rea-
sonable agreement with estimates calculated (Eq. 5)
from earlier (3-4), less precise Ki determinations at
room temperature and lower (2 mM) ATP concentra-
tions.
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FIGURE 4 Van't Hoff plots for the inhalational general anesthetics
diethyl ether (*), halothane (0), and methoxyflurane ( &). The mean
inhibition constants K, (on logarithmic scales) are plotted against the
reciprocal ofthe absolute temperature. Each mean Ki value is the aver-
age of (typically) 10 separate Ki determinations. The error bars are
standard errors; where not shown, these are smaller than the symbols.
The straight lines were drawn according to the method ofweighted least
squares, using (typically) 50 separate estimates of ln (K,) and weights
given by Eq. 7.
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20 discussion in reference 1) led them to report extremely
large decreases in both enthalpy and entropy on binding
of anesthetics.
Many workers (for a review, see reference 13) have
n-Butanol attempted to use values ofenthalpy and entropy changes
such as those in fable 1 to determine whether binding is
"enthalpy-dri\ven" or "entropy-driven". Since AG0 =
10 AH0 - TAS0, 1 hey reason that the total free energy
change AG' cani be subdivided into an enthalpy contri-
bution (AlJ') anid an entropy contribution (-TAS0).
However, althougth the enthalpy changes are indepen-
dent ofthe choice ofa standard state, the same is not true
for the free energy and entropy changes. One might be
n-Hexanol tempted, for exacmple, to look at the results for n-butanol
in Table 1 and say that its binding to luciferase is almost
entirely "en-thalpy-driven" (since AGO AllH -10.7
n-Heptanol
kJ mol-P and lAS0 -_ 0 kJ mol-'). However, if we
1 n-Heptanol had arbitrarily chosen 100 M anesthetic (rather than 1
M) as the standard state, the enthalpy change would re-
main as AH0 = -10.7 kJ mol-' but AG' and -TASO
would both decrease by RTln ( 100) = 11.2 kJ mol-', so
that AGO = -21.9 kJ mol-', AH0 = -10.7 kJ mol-' and
-TASO = -1 1.2 kJ mol -'. We might then conclude that
3. 35 3.40 3.45 3.50 3.55 3.6,0 the binding of butanol was equally driven by enthalpy
and entropy changes!
1/T (10-3 K-1) The above example illustrates the dangers of discuss-
ing free energy and entropy changes for ligand binding in
FIGURE 5 Van't Hoff plots for the alcohol general anesthetics n-bu- absolute terms. (Enthalpy changes, as already men-
tanol (*), n-hexanol (0), and n-heptanol (v). The mean inhibition tioned, do not suffer from standard state difficulties, and
constants K, (on logarithmic scales) are plotted against the reciprocal ' . .
a
of the absolute temperature. Each mean Ki value is the average of
(typically) 10 separate Ki determinations. The error bars are standard processes in the following sections.) However, one can
errors; where not shown, these are smaller than the symbols. The consider incremental A( AG0) and A(AS0) changes
straight lines were drawn according to the method of weighted least [and, of course, A(AHl) changes] between different li-
squares, using (typically) 30 separate estimates of In (Ki) and weights gands without standard state problems. In Fig. 6, we
given by Eq. 7. have plotted for luciferase data both - TASOatic
and AHOat .uc versus AGOatiC at 1 2°C (roughly the
mid-point temperature). The slopes of the solid least
Our values of transfer enthalpies and entropies squares lines drawn through the data points, when com-
(AH2at-luc and ASwat-luc respectively) from the pared to the slope ofthe dashed line assuming the theoret-
rNIk'lracao to% 1hnefvi_hnl, n1o aoc+,mAd4LLCUUS piian LU L1IC U eI1CtIC-D1InU1Ig POCKe-L are 1isLeU
in Table 1. Although enthalpies and entropies of transfer
for inhalational agents from the gas phase to firefly lucif-
erase were reported in an early study by Ueda and
Kamaya ( 12), their values are suspect for the following
reasons. First, it was not known until a decade after their
study was carried out that anesthetics inhibit luciferase
by competing with luciferin (3), and unfortunately they
used crude extracts of firefly lanterns containing un-
known (and possibly variable) concentrations of lucif-
erin. Since the binding of luciferin, and its variation with
temperature, can substantially affect the binding of anes-
thetics, it is not now possible to accurately reanalyze
their data. Furthermore, they interpreted their data us-
ing an old kinetic scheme inherited from earlier workers,
in which anesthetics only interact with a thermally inac-
tivated form of the enzyme. This unrealistic scheme (see
TABLE 1 Changes in standard Gibbs free energy, enthalpy and
entropy for transfer of anesthetics from aqueous buffer to the
luciferase enzyme at 200C
Anesthetic nobs AGO HatH.jc AsoaI.duc
kJ mol-' kJ mol' J mol-' K'
Halothane 50 -18.93 ± 0.05 -18.1 ± 1.6 2.8 ± 5.7
Methoxyflurane 50 -21.10 ± 0.03 -24.5 ± 1.0 -11.7 ± 3.5
Diethyl ether 50 -10.56 ± 0.06 -5.9 ± 1.8 16.0 ± 6.4
n-Butanol 29 -10.72 ± 0.04 -10.7 ± 1.1 0.05 ± 3.88
n-Hexanol 30 -15.85 ± 0.08 -29.5 ± 2.3 -46.7 ± 8.1
n-Heptanol 30 -16.17 ± 0.08 -19.3 ± 2.5 -10.7 ± 8.7
The standard state is 1 M anesthetic. The errors are standard errors
based on nobs measurements ofinhibition constantsKiover the tempera-
ture range from -5 to 20°C.
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FIGURE 6 Amongst the set of anesthetics studied, increasing potency
for inhibiting luciferase correlates with favorable enthalpy rather than
entropy changes. Values of -TAS' (A) and AH'a,_A (0) are
plotted against AG'.atic using data from Table 1 and the mid-point
temperature T = 285.15 K (i.e., 12°C). The error bars are standard
errors. The solid straight lines were drawn according to the method of
weighted least squares, using weighting factors proportional to the recip-
rocal of the squares of the standard errors of the ordinate values; the
slopes (±SEM) are -0.38 ± 0.39 for the upper (-TAS0) line and 1.38
± 0.40 for the lower (AH0) line. The dashed line is the theoretical
relationship AH0 AGO.
ical relationship AHll AG0, show that the incremental
changes A( AG0) in binding free energy are largely ac-
counted for by changes A( AH0) in enthalpy rather than
changes A( AS0) in entropy. In other words, although we
cannot deduce from our data the relative contributions
ofentropy and enthalpy to the absolute binding constant
of a given anesthetic, we can conclude that, on average,
increasing potency correlates with favorable changes in
enthalpy, with entropy changes, if anything, tending to
oppose enhanced binding.
Comparison with solvents and lipids
The most striking result of these experiments is that for
all general anesthetics studied, the enthalpies of transfer
(Table 1) from water to the anesthetic-binding site on
firefly luciferase are algebraically much more negative
(by >18 kJ mol-') than would be predicted from
transfer into simple solvents or lipid bilayers. This can be
seen from Table 2, where we have listed the correspond-
ing enthalpies of transfer of the same anesthetics from
water to cholesterol-containing lipid bilayers, olive oil
and alcohols (see also reference 14). It is clear from this
table that either no significant heat is released, or heat is
actually absorbed, when anesthetics bind to lipids or sol-
vents from water, whereas heat is released when anes-
thetics bind to luciferase from water.
It is tempting to suppose that these large excess (rela-
tive to solvents and lipid bilayers) negative enthalpies of
transfer from water to luciferase (see Table 2) underlie
the unusual sensitivity of this enzyme to anesthetics.
However, as the example in the last section demon-
strated, such a conclusion cannot be reliably drawn from
our current data. Nonetheless, this is an attractive hy-
pothesis, and future work, on the temperature depen-
dence of anesthetic binding to the insensitive form of
firefly luciferase which exists at low ATP concentrations
(5), should test this idea and help to clarify why some
proteins are sensitive to general anesthetics while most
are not.
Temperature dependence of general
anesthesia
The potency of a general anesthetic agent for inducing
general anesthesia in a given animal is a function ofboth
temperature and pressure. While the pressure depen-
dence has long been thought to provide clues as to how
TABLE 2 Enthalpies of transfer of general anesthetics from the
aqueous phase to firefly luciferase, olive oil, lipids and
n-alcohols
AHOater_site (kJ mol-')
Anesthetic Luciferase* Olive Oilt Lipid§ n-Alcoholll
Halothane -18 ± 2 +4 ± 5 +1 ±1 I
Methoxyflurane -24 ± 1 -6 ± 4 +1 ± 2
Diethyl ether -6 ± 2 +13 ± 2
n-Butanol -11 ± 1 - +9.3
n-Hexanol -30 ± 2 +6.5
n-Heptanol -19 ± 2 - +5.3
* Luciferase values (±SEM) are from Table 1. All other values (±SEM)
were calculated from slopes oflinear regions (always including 25°C) of
appropriate van't Hoff plots, using unweighted linear regressions on
data from the literature (see below). The olive oil and lipid values were
calculated from gas phase measurements using data (20, 22) on the
partitioning of the anesthetic gases between water and gas phases as a
function of temperature. tBunsen coefficients were calculated from
Ostwald oil/gas partition coefficients (20). 1Lipid/water partition coeffi-
cients were calculated as the ratios of Bunsen coefficients (22) for lipid
bilayers (egg lecithin/phosphatidic acid/cholesterol) and for water.
1Standard enthalpies ofsolution at 25°C, taken from reference 24. (-)
Relevant data or values are not available.
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general anesthetics act ( 15-18), less attention has been
paid to the temperature dependence. This neglect might
be justified on the grounds that animals, especially ho-
meotherms, have evolved physiological and behavioral
strategies for maintaining constant internal tempera-
tures. In addition, reduction ofbody temperature per se
might contribute towards the anesthetic endpoint ( 19).
Nonetheless, although a priori it is perhaps naive to
analyze the effects ofpressure and temperature on whole
animal anesthetic potencies in the same terms as for sim-
ple chemical reactions, it is interesting to perform the
exercise (1). If for simplicity we assume that tempera-
ture is primarily affecting the binding of anesthetics to
critical sites in the central nervous system, and that anes-
thesia occurs when some constant fraction of sites is oc-
cupied by one or more anesthetic molecules, it is easy to
show that ln (EC50) = AH/RT+ constant, where EC50 is
the concentration of anesthetic which anesthetizes 50%
ofa population ofanimals at an absolute temperature T,
and AH is the apparent enthalpy change for transferring
an anesthetic from any phase (here water) to the un-
known animal target sites. This means that one can cal-
culate AH from a van't Hoffplot of ln (EC50) versus T-'.
We have performed such an analysis for the three in-
halational agents used for the luciferase study for both a
"6warm-blooded" animal (the dog) and a "cold-
blooded" animal (the goldfish). For the dog, using gas-
eous minimum alveolar concentrations (MAC) in the
temperature range 26 to 43°C (19-21) and converting
these to aqueous EC50 values (20, 22), the apparent AH
(mean ± SEM) values are -11 ± 3 kJ mol -I for halo-
thane, -22 ± 8 kJ mol-I for methoxyflurane, and 8 ± 10
kJ mol' for diethyl ether. For the goldfish, using di-
rectly determined aqueous EC50 values (23) at 10, 20,
and 30°C, the apparent AH values (errors not given
since there were only three data points for each van't
Hoff plot) are -14 kJ mol-' for halothane, -14 kJ
mol-' for methoxyflurane, and 11 kJ mo'l for diethyl
ether.
In view ofthe simplifying assumptions made, it is inter-
esting that the apparent enthalpy changes for a given
agent are comparable (indeed equivalent within errors)
for the two different animals. Furthermore, for halo-
thane and methoxyflurane the enthalpy changes are (as
for luciferase) more negative for transfer of the anes-
thetics to the animal target sites than for transfer to lipid
bilayers. (Most lipid theories ofgeneral anesthesia postu-
late a disordering ofthe membrane by anesthetics, which
then interferes with protein function. Such disordering
would be mimicked by increasing temperature, thus
making the animal enthalpy changes more positive (not
more negative as observed) than those for lipid partition-
ing.) Thus these results are consistent with, but certainly
do not prove, the idea that the primary animal target
sites for general anesthesia are proteins whose sensitivity
to anesthetics derives from the same type ofmechanism
underlying the sensitivity of firefly luciferase.
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